SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-22 |
| Reported value | $241,917,580 |
| Positions | 4 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| CYTOKINETICS, INC | CYTK | COM | $83,519,594 | 980,392 |
| ZENAS BIOPHARMA, INC. | ZBIO | COM | $60,611,247 | 2,388,150 |
| KAILERA THERAPEUTICS | KLRA | COM | $54,091,515 | 2,455,357 |
| BIOHAVEN LTD | BHVN | COM | $43,695,224 | 2,936,507 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.